4 completed, 1 active not recruiting, 1 terminated, 1 unknown. 7 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 4, Active not recruiting 1, Terminated 1, Unknown 1 |
| Phase 3 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
Follow Gelatin: new trials by email Literature Review of Gelatin trials Research Report on Gelatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance. Turmeric extract, Control: Placebo. 500mg gelatin in capsules 2 times a day - Cognitive Decline, Subjective Cognitive Impairment | Phase 2 / Phase 3 | Active not recruiting | Instituto Mexicano del Seguro Social | 100 | 2025-02-20 | 2026-03-25 |
| Acetazolamide Efficacy in Ataxia in PMM2-CDG Placebo, Acetazolamide - Pmm2-CDG, CDG1A | Phase 2 / Phase 3 | Terminated | Mayo Clinic | 25 | 2021-03-17 | 2025-03-20 |
| Venavine Intensive® in the Treatment of Symptoms Associated With Chronic Venous Insufficiency Gelatine capsule, Venavine Intensive® - Venous Insufficiency | Phase 2 | Completed | University of Johannesburg | 40 | 2015-02-01 | 2016-05-19 |
| Oral DS107 in Moderate to Severe Atopic Dermatitis Oral DS107, Placebo - Atopic Dermatitis | Phase 2 | Completed | Dignity Sciences Ltd. | 102 | 2015-01-01 | 2022-10-07 |
| The Efficacy of Venavine Intensive® on the Quality of Life in Females With Chronic Venous Insufficiency Gelatine Capsule, Venavine Intensive® - Venous Insufficiency | Phase 2 | Completed | University of Johannesburg | 40 | 2015-01-01 | 2016-05-19 |
| Preoperative Oral Dexamethasone to Improve Recovery After Surgery Oral dexamethasone, Ondansetron, Gelatin capsule - Breast Cancer | Phase 2 | Unknown | University of Manitoba | 80 | 2014-08-01 | 2014-09-09 |
| Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction Lenograstim (GRANOCYTE)=GCSF, Sitagliptin (Januvia), Sodium Chloride (NaCl) 0.9 % - Acute Myocardial Infarction | Phase 2 / Phase 3 | Completed | Ludwig-Maximilians - University of Munich | 174 | 2008-03-01 | 2022-08-25 |
Bronchiolitis Obliterans Syndrome (2) · Venous Insufficiency (2) · Breast Neoplasms (1) · Cognitive Dysfunction (1) · Congenital disorder of glycosylation type 1A (1) · Dermatitis, Atopic (1) · Insulin Resistance (1) · Myocardial Infarction (1) · Postoperative Nausea and Vomiting (1) · Vomiting (1)
University of Johannesburg (2) · Dignity Sciences Ltd. (1) · Instituto Mexicano del Seguro Social (1) · Ludwig-Maximilians - University of Munich (1) · Mayo Clinic (1) · University of Manitoba (1)
Canada (2) · South Africa (2) · United States (2) · Germany (1) · Mexico (1)
Radmila Razlog, M.TechHom (2) · Eva Morava-Kozicz, MD, PhD (1) · Faisal Siddiqui, MD (1) · John Climax, Ph.D. (1) · Svetlana Dubrovna, PhD (1) · Wolfgang M Franz, Prof. Dr. (1)